Publications by authors named "Pauline Bollen"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

204

Total Likes

190

Extended Reach

144,694

Social Features

41
I
Influence of age and co-medication on dolutegravir glucuronidation in paediatric patients.
Tom G Jacobs, Hylke Waalewijn, Lily Houlden, Pauline D J Bollen, Annet Nanduudu

Br J Clin Pharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents.
Hardik Chandasana, Mita Thapar, Siobhan Hayes, Mark Baker, Diana M Gibb, Pauline Bollen

Clin Pharmacokinet· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial.
Anna Turkova, Hylke Waalewijn, Man K Chan, Pauline D J Bollen, Mutsa F Bwakura-Dangarembizi

Lancet HIV· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial.
Hylke Waalewijn, Man K Chan, Pauline D J Bollen, Hilda A Mujuru, Shafic Makumbi

Lancet HIV· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Pregnancy on the Pharmacokinetics of Total and Unbound Dolutegravir and Its Main Metabolite in Women Living With Human Immunodeficiency Virus.
Pauline Bollen, Jolien Freriksen, Deborah Konopnicki, Katharina Weizsäcker, Carmen Hidalgo Tenorio

Clin Infect Dis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial.
Pauline D J Bollen, Cecilia L Moore, Hilda A Mujuru, Shafic Makumbi, Adeodata R Kekitiinwa

Lancet HIV· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of an UPLC-MS/MS bioanalytical method for simultaneous quantification of the antiretroviral drugs dolutegravir, elvitegravir, raltegravir, nevirapine and etravirine in human plasma.
Pauline D J Bollen, Marga J A de Graaff-Teulen, Stein Schalkwijk, Nielka P van Erp, David M Burger

J Chromatogr B Analyt Technol Biomed Life Sci· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crushing of dolutegravir fixed-dose combination tablets increases dolutegravir exposure.
Marieke Roskam-Kwint, Pauline Bollen, Angela Colbers, Marjolijn Duisenberg-van Essenberg, Veroniek Harbers

J Antimicrob Chemother· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir is not removed during hemodialysis.
Pauline D J Bollen, Bart J A Rijnders, Marga J A Teulen, David M Burger

AIDS· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacokinetics and pharmacodynamics of dolutegravir used as a single tablet regimen for the treatment of HIV-1 infection.
Pauline Bollen, Peter Reiss, Jonathan Schapiro, David Burger

Expert Opin Drug Saf· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe verapamil intoxication despite correct use of low-dose verapamil.
Loes Mandigers, Pauline D J Bollen, Peter J Bijlstra, Els Brands

Drug Metab Pers Ther· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of a chronic reduction of short-wavelength light input on melatonin and sleep patterns in humans: evidence for adaptation.
Marina C Giménez, Domien G M Beersma, Pauline Bollen, Matthijs L van der Linden, Marijke C M Gordijn

Chronobiol Int· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis